CRMD
CorMedix Inc
Price:  
5.11 
USD
Volume:  
536,520.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

CRMD WACC - Weighted Average Cost of Capital

The WACC of CorMedix Inc (CRMD) is 7.5%.

The Cost of Equity of CorMedix Inc (CRMD) is 10.40%.
The Cost of Debt of CorMedix Inc (CRMD) is 5.00%.

Range Selected
Cost of equity 8.40% - 12.40% 10.40%
Tax rate 3.30% - 10.10% 6.70%
Cost of debt 5.00% - 5.00% 5.00%
WACC 6.6% - 8.4% 7.5%
WACC

CRMD WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.99 1.33
Additional risk adjustments 0.0% 0.5%
Cost of equity 8.40% 12.40%
Tax rate 3.30% 10.10%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 6.6% 8.4%
Selected WACC 7.5%